Born in 1952. HD in Financial and Management Accounting, Copenhagen Business School
Torben brings decades of leadership experience in the international life science and diagnostics sector. He has served as President and CEO of Biotage AB, where he led significant growth and acquisitions, taking the company from a valuation of 500 MSEK to 15 BSEK. His career includes top executive roles at Affibody AB, Karo Bio AB, and Dako A/S, as well as financial leadership positions in major Danish companies. Torben currently chairs Genovis AB, Boule Diagnostics, and Argus Eye, and serves on the boards of Nova Instruments Inc. and other organizations. He also acts as an advisor to private equity and life science companies.
Board member since 2025.
Other assignments and positions:
Chairman of Genovis AB, Boule Diagnostics, Argus Eye. Board member of Nova Instruments Inc. Former Chairman of Biotage AB (2019–2023).
Shares in Integrum, own and party holders:
B-Shares: 93 750
Independent in relation to the Company and company management as well as independent in relation to the Company’s larger shareholders.